99% Savings - Buy Just @1 Rs X
Glyree MP 1 Tablet ER is a prescription medicine that is available as a Tablet. It is typically used for the treatment of Diabetes. Other than this, Glyree MP 1 Tablet ER has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Glyree MP 1 Tablet ER is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Common side effects of Glyree MP 1 Tablet ER include Nausea or vomiting, Diarrhoea, Headache. While these are the most often observed Glyree MP 1 Tablet ER side effects, there are can be others also. These have been listed below. Normally, these side effects of Glyree MP 1 Tablet ER are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Glyree MP 1 Tablet ER has a Unknown effect for pregnant women and Safe effect on lactating mothers. It is important to know if Glyree MP 1 Tablet ER has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Glyree MP 1 Tablet ER related warnings section.
Glyree MP 1 Tablet ER is contraindicated in people with pre-existing medical conditions like Liver Disease, Kidney Disease as it can result in adverse effects.
Drug reaction of Glyree MP 1 Tablet ER with other medicines has been reported. A complete list of these interactions is given below.
You should also be aware that Glyree MP 1 Tablet ER is not safe while driving, and is not addiction.
Glyree MP 1 Tablet ER is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glyree MP 1 Tablet ER safe for pregnant women?
It is not known what effect Glyree MP will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Glyree MP 1 Tablet ER safe during breastfeeding?
Glyree MP is safe for breastfeeding women.
What is the effect of Glyree MP 1 Tablet ER on the Kidneys?
There can be some harmful effects on your kidneys after taking Glyree MP. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Glyree MP 1 Tablet ER on the Liver?
Glyree MP may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Glyree MP 1 Tablet ER on the Heart?
Glyree MP is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Glyree MP 1 Tablet ER unless your doctor advises you to do so -
Is this Glyree MP 1 Tablet ER habit forming or addictive?
No, you will not get addicted to Glyree MP 1 Tablet ER.
Is it safe to drive or operate heavy machinery when consuming?
After taking Glyree MP 1 Tablet ER you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Glyree MP 1 Tablet ER only as per medical advice.
Is it able to treat mental disorders?
No, Glyree MP 1 Tablet ER is not used to treat mental disorders.
Interaction between Food and Glyree MP 1 Tablet ER
There isn't any research available on the side effects of taking Glyree MP 1 Tablet ER with food.
Interaction between Alcohol and Glyree MP 1 Tablet ER
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Glyree MP 1 Tablet ER.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033